These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64. New drugs and methods of doping and manipulation. Thevis M, Kohler M, Schänzer W. Drug Discov Today; 2008 Jan; 13(1-2):59-66. PubMed ID: 18190865 [Abstract] [Full Text] [Related]
65. Doping control analysis of recombinant human erythropoietin, darbepoetin alfa and methoxy polyethylene glycol-epoetin beta in equine plasma by nano-liquid chromatography-tandem mass spectrometry. Yu NH, Ho EN, Wan TS, Wong AS. Anal Bioanal Chem; 2010 Apr; 396(7):2513-21. PubMed ID: 20148243 [Abstract] [Full Text] [Related]
66. Characterization of two major urinary metabolites of the PPARdelta-agonist GW1516 and implementation of the drug in routine doping controls. Thevis M, Möller I, Thomas A, Beuck S, Rodchenkov G, Bornatsch W, Geyer H, Schänzer W. Anal Bioanal Chem; 2010 Apr; 396(7):2479-91. PubMed ID: 19946680 [Abstract] [Full Text] [Related]
69. Testosterone and doping control. Saudan C, Baume N, Robinson N, Avois L, Mangin P, Saugy M. Br J Sports Med; 2006 Jul; 40 Suppl 1(Suppl 1):i21-4. PubMed ID: 16799097 [Abstract] [Full Text] [Related]
70. A multi-targeted liquid chromatography-mass spectrometry screening procedure for the detection in human urine of drugs non-prohibited in sport commonly used by the athletes. Mazzarino M, Cesarei L, de la Torre X, Fiacco I, Robach P, Botrè F. J Pharm Biomed Anal; 2016 Jan 05; 117():47-60. PubMed ID: 26342446 [Abstract] [Full Text] [Related]
72. Determination of tuaminoheptane in doping control urine samples. Thevis M, Sigmund G, Koch A, Schänzer W. Eur J Mass Spectrom (Chichester); 2007 Jan 05; 13(3):213-21. PubMed ID: 17881789 [Abstract] [Full Text] [Related]
73. Procedures for monitoring recombinant erythropoietin and analogues in doping control. Segura J, Pascual JA, Gutiérrez-Gallego R. Anal Bioanal Chem; 2007 Aug 05; 388(7):1521-9. PubMed ID: 17516052 [Abstract] [Full Text] [Related]
74. Simplifying and expanding analytical capabilities for various classes of doping agents by means of direct urine injection high performance liquid chromatography high resolution/high accuracy mass spectrometry. Görgens C, Guddat S, Thomas A, Wachsmuth P, Orlovius AK, Sigmund G, Thevis M, Schänzer W. J Pharm Biomed Anal; 2016 Nov 30; 131():482-496. PubMed ID: 27693991 [Abstract] [Full Text] [Related]
75. Drug testing data from the 2007 Pan American Games: delta13C values of urinary androsterone, etiocholanolone and androstanediols determined by GC/C/IRMS. Aguilera R, Chapman TE, Pereira H, Oliveira GC, Illanes RP, Fernandes TF, Azevedo DA, Neto FA. J Steroid Biochem Mol Biol; 2009 Jul 30; 115(3-5):107-14. PubMed ID: 19428237 [Abstract] [Full Text] [Related]
76. Intranasal delivery of Natesto® testosterone gel and its effects on doping markers. Miller GD, Nair V, Morrison MS, Summers M, Willick SE, Eichner D. Drug Test Anal; 2016 Nov 30; 8(11-12):1197-1203. PubMed ID: 27714988 [Abstract] [Full Text] [Related]
79. Mass spectrometric determination of insulins and their degradation products in sports drug testing. Thevis M, Thomas A, Schänzer W. Mass Spectrom Rev; 2008 Nov 30; 27(1):35-50. PubMed ID: 18000882 [Abstract] [Full Text] [Related]